282 Evidence as to controlled drugs and medicinal products.S
(1)For the purposes of any criminal proceedings, evidence given by an authorised forensic scientist, either orally or in a report purporting to be signed by him, that a substance which satisfies either of the conditions specified in subsection (2) below is—
(a)a particular controlled drug or medicinal product; or
(b)a particular product which is listed in the British Pharmacopoeia as containing a particular controlled drug or medicinal product,
shall, subject to subsection (3) below, be sufficient evidence of that fact notwithstanding that no analysis of the substance has been carried out.
(2)Those conditions are—
(a)that the substance is in a sealed container bearing a label identifying the contents of the container; or
(b)that the substance has a characteristic appearance having regard to its size, shape, colour and manufacturer’s mark.
(3)A party proposing to rely on subsection (1) above (“the first party”) shall, not less than 14 days before the [F1relevant] diet, serve on the other party (“the second party”)—
(a)a notice to that effect; and
(b)where the evidence is contained in a report, a copy of the report,
and if the second party serves on the first party, not more than seven days after the date of service of the notice on him, a notice that he does not accept the evidence as to the identity of the substance, subsection (1) above shall not apply in relation to that evidence.
[F2(3A)In subsection (3) above, “the relevant diet” means—
(a)in the case of proceedings in the High Court, the preliminary hearing;
(b)in any other case, the trial diet.]
(4)A notice or copy report served in accordance with subsection (3) above shall be served in such manner as may be prescribed by Act of Adjournal; and a written execution purporting to be signed by the person who served the notice or copy together with, where appropriate, the relevant post office receipt shall be sufficient evidence of such service.
(5)In this section—
“controlled drug” has the same meaning as in the M1Misuse of Drugs Act 1971; and
“medicinal product” has the same meaning as in the M2Medicines Act 1968.
Textual Amendments
F1Word in s. 282(3) substituted (1.2.2005) by Criminal Procedure (Amendment) (Scotland) Act 2004 (asp 5), ss. 25, 27(1), Sch. para. 51(a); S.S.I. 2004/405, art. 2(1), Sch. 1 (with savings in arts. 3-5)
F2S. 282(3A) inserted (1.2.2005) by Criminal Procedure (Amendment) (Scotland) Act 2004 (asp 5), ss. 25, 27(1), Sch. para. 51(b); S.S.I. 2004/405, art. 2(1), Sch. 1 (with savings in arts. 3-5)
Marginal Citations